JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jones, L. F.
Right arrow Articles by Brody, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jones, L. F.
Right arrow Articles by Brody, M. J.

Coronary blood flow in rats is dependent on the release of vascular nitric oxide

LF Jones and MJ Brody

Department of Pharmacology, University of Iowa, Iowa City.

The present study evaluated the role of nitric oxide (NO) in determining basal coronary vascular tone and the mechanism by which NO regulates coronary blood flow. Sprague-Dawley rats were anesthetized and instrumented for recording arterial pressure (AP), heart rate (HR) and coronary blood flow (CBF; Doppler). In rats without ventricular pacing, N-nitro-L-arginine methyl ester (LNAME) (10 mumol/kg, i.v.), an inhibitor of NO synthesis, produced an increase in AP and a decrease in HR. The LNAME-induced bradycardia was inhibited by sinoaortic denervation. LNAME also produced a reduction in left anterior descending (LAD) CBF. When the same dose of LNAME was administered to a separate group of rats measuring CBF in the right coronary artery (RCA), the decrease in CBF was found to be more prominent in the LAD compared to the RCA. Removal of the sympathetic innervation to the heart and adrenal demedullation did not alter the decrease in CBF, indicating that the effects of LNAME were not centrally mediated. To determine if the effect of LNAME on CBF was due to a direct action on the coronary vasculature or was secondary to the change in HR, dose- response curves were performed for LNAME (0.3-300 mumol/kg, i.v.) in rats with ventricular pacing. Under these conditions, LNAME still produced an increase in AP and a decrease in CBF, resulting in an increase in coronary vascular resistance. Administration of L-arginine (100-300 mg/kg, i.v.) resulted in a reversal of the cardiovascular effects of LNAME with the reversal being sustained for 1 to 5 min.(ABSTRACT TRUNCATED AT 250 WORDS)

Volume 260, Issue 2, pp. 627-631, 02/01/1992
Copyright © 1992 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
J. A. Gutierrez, S. G. Clark, A. D. Giulumian, and L. C. Fuchs
Superoxide Anions Contribute to Impaired Regulation of Blood Pressure by Nitric Oxide During the Development of Cardiomyopathy
J. Pharmacol. Exp. Ther., September 1, 1997; 282(3): 1643 - 1649.
[Abstract] [Full Text]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
J. M. Pearl, H. Laks, D. C. Drinkwater, T. J. Sorensen, P. Chang, A. S. Aharon, R. E. Byrns, and L. J. Ignarro
Loss of endothelium-dependent vasodilatation and nitric oxide release after myocardial protection with University of Wisconsin solution
J. Thorac. Cardiovasc. Surg., January 1, 1994; 107(1): 257 - 264.
[Abstract] [Full Text]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1992 by the American Society for Pharmacology and Experimental Therapeutics.